AVITA Medical to Participate in Lake Street Best Ideas Growth Conference and Morgan Stanley Healthcare Conference
AVITA Medical’s senior leadership will meet investors and join a webcast fireside chat at two New York healthcare conferences in September 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
AVITA Medical (RCEL) will participate in two investor events in New York in September 2026: Lake Street Capital Markets’ 10th Annual Best Ideas Growth Conference on September 10 and Morgan Stanley’s 24th Annual Global Healthcare Conference on September 16.
President and CEO Cary Vance and CFO David O’Toole will host investor meetings at both conferences and join a fireside chat at the Morgan Stanley event at 1:05 p.m. ET. A live audio webcast and 90-day replay of this fireside chat will be accessible in the Investor Relations section of AVITA Medical’s website.
Details
News Market Reaction – RCEL
On Sep 3, the first trading day after this news, RCEL closed 1.67% above the previous close. Relative volume reached 2.1x the daily average during tracking.
Data tracked by StockTitan Argus for the Sep 3 session.
Key Figures
- Lake Street conference edition
- 10th Annual
- Best Ideas Growth Conference
- Lake Street conference date
- September 10, 2026
- Investor meetings in New York
- Morgan Stanley conference edition
- 24th Annual
- Global Healthcare Conference
- Morgan Stanley conference date
- September 16, 2026
- Fireside chat in New York
- Fireside chat time
- 1:05 p.m. ET
- September 16, 2026
- AEST webcast time
- 3:05 a.m. AEST
- September 17, 2026
- Replay availability
- 90 days
- Morgan Stanley fireside chat webcast
Historical Context
-
PermeaDerm study reported economic advantage and comparable clinical outcomes
-
Webinar scheduled to review Q2 financial and business highlights
-
Company announced participation in Canaccord Growth Conference
-
Revenue growth and raised 2026 guidance accompanied quarterly results
-
Second-quarter financial results release date and webcast were announced
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
VALENCIA, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today announced that its senior management will participate in the following investor conferences:
- Lake Street Capital Markets 10th Annual Best Ideas Growth (BIG10) Conference – Thursday, September 10, 2026 | Investor meetings with Cary Vance, President and Chief Executive Officer, and David O’Toole, Chief Financial Officer | New York
- Morgan Stanley 24th Annual Global Healthcare Conference – Wednesday, September 16, 2026 | 1:05 p.m. ET fireside chat with Cary Vance and David O’Toole | New York
AVITA Medical management will host investor meetings at both conferences, and a live audio webcast of the Morgan Stanley fireside chat (September 16, 2026, 1:05 p.m. ET | September 17, 2026, 3:05 a.m. AEST) will be available for replay for 90 days on the Investor Relations section of AVITA Medical’s website, at https://ir.avitamedical.com/events-and-presentations
To request an invitation or to schedule a one-on-one meeting at either conference, please contact your Lake Street or Morgan Stanley representative.
About AVITA Medical, Inc.
AVITA Medical® is a leading therapeutic acute wound care company delivering transformative solutions. Our technologies are designed to optimize wound healing, effectively accelerating the time to patient recovery. At the forefront of our platform is RECELL®, approved by the FDA for the treatment of thermal burn and trauma wounds. RECELL harnesses the healing properties of a patient’s own skin to create Spray-On Skin™, offering an innovative solution for improved clinical outcomes at the point-of-care. In the U.S., AVITA Medical also holds the exclusive rights to market, sell, and distribute Cohealyx®, an AVITA Medical-branded collagen-based dermal matrix, and the rights to manufacture, market, sell, and distribute PermeaDerm®, a biosynthetic wound matrix.
In international markets, RECELL is approved to promote skin healing in a wide range of applications, including thermal burn and trauma wounds. RECELL and RECELL GO® are CE-marked in Europe, have TGA certification in Australia, and are listed with Medsafe in New Zealand; RECELL is PMDA-approved in Japan.
To learn more, visit www.avitamedical.com.
Investor & Media Contact:
Ben Atkins
Phone +1-805 341 1571
investor@avitamedical.com | media@avitamedical.com
Authorized for release by the Chief Financial Officer of AVITA Medical, Inc.
©2026 AVITA Medical. AVITA Medical®, the AVITA Medical logo, Cohealyx®, RECELL®, RECELL GO®, and Spray-On Skin™ Cells are trademarks of AVITA Medical. PermeaDerm® is a registered trademark owned by Stedical Scientific, Inc. All other trademarks are the properties of their respective owners.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.